A carregar...

Timing of monoclonal antibody for seasonal RSV prophylaxis in the United Kingdom

Respiratory syncytial virus (RSV) infection produces more severe disease and increased hospitalization rates in high-risk babies. The monoclonal antibody palivizumab offers protection against complications, and the first of five monthly doses should be administered before the onset of community RSV...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: GODDARD, N. L., COOKE, M. C., GUPTA, R. K., NGUYEN-VAN-TAM, J. S.
Formato: Artigo
Idioma:Inglês
Publicado em: Cambridge University Press 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2870551/
https://ncbi.nlm.nih.gov/pubmed/16753078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S0950268806006601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!